Trial
NCT04966676
Study of Nivolumab-Ipilimumab and cfDNA in Lung Cancer
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University Health Network, Toronto
Collaborators
Bristol-Myers Squibb
Condition
Non Small Cell Lung Cancer
Intervention
cfDNA blood test
Why stopped
Low accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-01-08